is intended to ensure bioequivalence of the original drugs and determine whether their bioequivalence is not affected by relocation of the sites (ingredients and methods) and we offer comparative dissolution and physicochemical bioequivalence testing services.
In particular, the Drug Research Center is a dedicated bioequivalence analysis institute which was established for the first time in Korea with analysis techniques and validation know-how of more than 100 ingredients accumulated for the past 15 years. It also provides dissolution testing services which are required to establish standard criteria for the research and development of formulations.